Glaukos (GKOS) Total Non-Current Liabilities (2014 - 2026)
Glaukos (GKOS) reported Total Non-Current Liabilities of $192.9 million for Q1 2026, up 6.62% year-over-year from $180.9 million in Q1 2025, and down 6.17% on a QoQ basis from $205.6 million in Q4 2025.
Glaukos (GKOS) has 13 years of Total Non-Current Liabilities data on file, last reported at $192.9 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 6.62% year-over-year to $192.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $192.9 million (up 6.62% YoY) and the FY2025 annual result came in at $205.6 million, up 10.86% from the prior year.
- Total Non-Current Liabilities eased to $192.9 million in Q1 2026 per GKOS's latest filing, from $205.6 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $482.6 million in Q1 2024 and bottomed at $180.9 million in Q1 2025.
- The 5-year median for Total Non-Current Liabilities is $445.2 million (2022), against an average of $338.5 million.
- Peak annual rise in Total Non-Current Liabilities reached 10.86% in 2025, while the deepest fall reached 62.51% in 2025.
- Tracing GKOS's Total Non-Current Liabilities over 5 years: stood at $462.1 million in 2022, then increased by 0.61% to $464.9 million in 2023, then sank by 60.11% to $185.5 million in 2024, then rose by 10.86% to $205.6 million in 2025, then retreated by 6.17% to $192.9 million in 2026.
- Per Business Quant, the three latest GKOS Total Non-Current Liabilities figures stand at $192.9 million (Q1 2026), $205.6 million (Q4 2025), and $198.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 192.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192.91 Mn |
| Dec 31, 2025 | 205.59 Mn |
| Sep 30, 2025 | 198.75 Mn |
| Jun 30, 2025 | 191.07 Mn |
| Mar 31, 2025 | 180.93 Mn |
| Dec 31, 2024 | 185.45 Mn |
| Sep 30, 2024 | 235.95 Mn |
| Jun 30, 2024 | 233.84 Mn |
| Mar 31, 2024 | 482.61 Mn |
| Dec 31, 2023 | 464.90 Mn |
| Sep 30, 2023 | 458.18 Mn |
| Jun 30, 2023 | 455.02 Mn |
| Mar 31, 2023 | 452.89 Mn |
| Dec 31, 2022 | 462.10 Mn |
| Sep 30, 2022 | 450.42 Mn |
| Jun 30, 2022 | 459.35 Mn |
| Mar 31, 2022 | 445.18 Mn |
| Dec 31, 2021 | 453.05 Mn |
| Sep 30, 2021 | 454.10 Mn |
| Jun 30, 2021 | 450.82 Mn |
| Mar 31, 2021 | 425.41 Mn |
| Dec 31, 2020 | 331.02 Mn |
| Sep 30, 2020 | 326.97 Mn |
| Mar 31, 2020 | 133.93 Mn |
| Dec 31, 2019 | 139.96 Mn |
| Sep 30, 2019 | 113.36 Mn |
| Jun 30, 2019 | 110.87 Mn |
| Mar 31, 2019 | 39.52 Mn |
| Dec 31, 2018 | 30.37 Mn |
| Sep 30, 2018 | 24.77 Mn |
| Jun 30, 2018 | 20.37 Mn |
| Mar 31, 2018 | 18.65 Mn |
| Dec 31, 2017 | 26.79 Mn |
| Sep 30, 2017 | 19.81 Mn |
| Jun 30, 2017 | 19.12 Mn |
| Mar 31, 2017 | 14.64 Mn |
| Dec 31, 2016 | 16.94 Mn |
| Sep 30, 2016 | 18.84 Mn |
| Jun 30, 2016 | 18.73 Mn |
| Mar 31, 2016 | 17.99 Mn |
| Dec 31, 2015 | 21.37 Mn |
| Sep 30, 2015 | 22.82 Mn |
| Jun 30, 2015 | 33.11 Mn |
| Dec 31, 2014 | 29.53 Mn |